Pharmaceuticals & Biotechnology (4570)

23,289.13
   
  • 52 Week High: 28,702.61
  • 52 Week Low: 20,721.97

Latest ShareCast News

Oxford Nanopore announces new 2030 targets as interim losses narrow

By Michele Maatouk

Date: Wednesday 19 Aug 2026

(Sharecast News) - Oxford Nanopore Technologies announced a new 2030 revenue target of more than $700m on Wednesday, as it reported a narrowing of its interim losses as revenue ticked higher, driven by strong adoption in EMEAI and across Applied end markets.

Pharmaceuticals & Biotechnology Regulatory News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 23,289.13
Closing Price Change 712.93
% Change 2.50 %
18-Aug-26 Close 23,289.13

Top Risers

Price Change
NFX 0.17p +17.9%
ONT 136.90p +12.0%
EDEN 2.43p +7.8%
BVXP 1,675.00p +6.3%
PRTC 119.40p +3.1%
AZN 12,108.00p +2.6%
GSK 1,926.00p +2.0%
GNS 2,314.00p +1.8%
HLN 360.50p +1.4%
CIZ 1.50p +1.4%

Top Fallers

Price Change
FUM 0.40p -8.9%
IMM 3.30p -8.7%
4BB 464.29p -5.6%
AGY 5.10p -2.9%
HCM 184.00p -2.6%
TLM 5.75p -2.5%
SAR 27.77p -2.4%
APTA 0.36p -2.3%
HEMO 619.50p -2.0%
SCLP 9.53p -1.2%

Top of Page